Okulovision, Inc.

UEI
EYWDSUVA7HQ9
CAGE
9YP94
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
okulovision.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Regenerating the (para)foveal macula: development of a candidate combination RPE-cone cell therapy for treating… R43EY036349 National Eye Institute (NIH) $0

Quick answers

Is Okulovision, Inc. registered in SAM.gov?

Okulovision, Inc.'s SAM.gov registration expired on July 18, 2025.

What is Okulovision, Inc.'s most recent federal award?

Okulovision, Inc.'s most recent federal grant award is Regenerating the (para)foveal macula: development of a candidate combination RPE-cone cell therapy for treating… (R43EY036349), from National Eye Institute (NIH), on September 29, 2024.

On GovTribe

See Okulovision, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login